Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · Real-Time Price · USD
0.192
-0.010 (-5.14%)
At close: Oct 29, 2024, 4:00 PM
0.196
+0.004 (2.14%)
After-hours: Oct 29, 2024, 6:31 PM EDT

Novo Integrated Sciences Revenue

Novo Integrated Sciences had revenue of $3.15M in the quarter ending May 31, 2024, a decrease of -4.28%. This brings the company's revenue in the last twelve months to $13.52M, up 1,102.98% year-over-year. In the fiscal year ending August 31, 2023, Novo Integrated Sciences had annual revenue of $12.57M with 7.11% growth.

Revenue (ttm)
$13.52M
Revenue Growth
+1,102.98%
P/S Ratio
0.24
Revenue / Employee
$58,769
Employees
230
Market Cap
3.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 202312.57M834.08K7.11%
Aug 31, 202211.74M2.43M26.14%
Aug 31, 20219.31M1.44M18.38%
Aug 31, 20207.86M-1.56M-16.57%
Aug 31, 20199.42M527.36K5.93%
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nuwellis 9.01M
Genetic Technologies 6.45M
Petros Pharmaceuticals 4.12M
Fresh2 Group 2.34M
Azitra 408.20K
Biodexa Pharmaceuticals 104.90K
Revenue Rankings